Clinical Trial

Efficacy and Safety of Etrasimod in Elderly Patients With Ulcerative Colitis

Recruiting
View on ClinicalTrials.gov →
Summary
Eligible patients will be identified in regular clinical practice. After providing thorough explanation and obtaining voluntary written informed consent, the clinical course, adverse events, endoscopic findings, and histopathological changes in biopsy specimens after Etrasimod administration will be prospectively collected and analyzed.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-19; most recent amendment 2026-07-19.
Trial Details
NCT Number NCT07243639
Lead Sponsor Showa Inan General Hospital
Conditions Ulcerative Colitis (Disorder)
Enrollment 30 participants
Start Date 2025-10-01
Primary Completion 2027-09-30 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-21